Danaher CEO To Comment On Financial Performance
Danaher Corporation (DHR)
Last danaher corporation earnings: 1/30 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.danaher.com
Company Research
Source: PR Newswire
WASHINGTON, Jan. 7, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Thomas P. Joyce, Jr., will comment tomorrow on the Company's fourth quarter 2018 performance in a presentation at the J.P. Morgan Healthcare Conference in San Francisco, California at 8:00 a.m. PT. Mr. Joyce will communicate that fourth quarter 2018 core revenue growth is expected to be above the Company's previously announced guidance and adjusted diluted net earnings per share is expected to be at or near the high-end of the Company's previously announced guidance.As previously announced, Danaher will hold its quarterly earnings conference call for the fourth quarter and year-end 2018 on Tuesday, January 29, 2019 at 8:00 a.m. ET.ABOUT DANAHERDanaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has le
Show less
Read more
Impact Snapshot
Event Time:
DHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DHR alerts
High impacting Danaher Corporation news events
Weekly update
A roundup of the hottest topics
DHR
News
- Oligonucleotide Synthesis Market Worth $19.7 billion | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- The Zacks Analyst Blog Highlights Danaher, Regeneron Pharmaceuticals, Palo Alto Networks, Workday and American Electric Power [Yahoo! Finance]Yahoo! Finance
- Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks [Yahoo! Finance]Yahoo! Finance
- Danaher Co. (NYSE: DHR) had its price target raised by analysts at Citigroup Inc. from $280.00 to $290.00. They now have a "buy" rating on the stock.MarketBeat
- Danaher Co. (NYSE: DHR) had its price target raised by analysts at TD Cowen from $280.00 to $290.00. They now have a "buy" rating on the stock.MarketBeat
DHR
Earnings
- 4/23/24 - Beat
DHR
Sec Filings
- 4/26/24 - Form 4
- 4/25/24 - Form 4
- 4/25/24 - Form 4
- DHR's page on the SEC website